CIDRAP newsletters options
Preventive use of bamlanivimab lowered the risk of symptomatic COVID-19 in staff and residents of skilled nursing and assisted living facilities in the United States, according to a study yesterday in JAMA.
Nearly 80% of US patients hospitalized for COVID-19 received antibiotics from March through October 2020, researchers from the Centers for Disease Control and Prevention (CDC) reported yesterday in Open Forum Infectious Diseases.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
Plus, in the United Kingdom, the Delta variant (B1617.2) is surpassing the proportion of Alpha cases (B117).
Also, the White House says it will share 25 million vaccine doses with countries in need of supply.
Only 13% had bacterial infections, but 85% received one or more antibiotics.
Tests showed COVID-19 antibodies persisted for 6 months in most dental workers.
Guidelines for antibiotic initiation and discontinuation for community-acquired bacterial pneumonia (CABP) in COVID-19 patients at a Chicago hospital were associated with reduced antibiotic prescribing and days of therapy (DOT), researchers reported yesterday in BMC Infectious Diseases.
US intensive care unit (ICU) beds increased a net 10% amid the COVID-19 pandemic, from April to July 2020, over 2019 baselines, according to a study today in Infection Control & Hospital Epidemiology.
Risks were lowest for patients in clinics with more isolation rooms and mask policies for all patients.
Uganda (191% rise in cases), Colombia (40%), Malaysia (38%), and Bahrain (32%) are getting hit hard.
The administration hopes to vaccinate at least 70% of Americans with at least one dose by July 4.
Prophylactic hydroxychloroquine treatment was not associated with any risk difference for COVID-19 infection, according to an International Journal of Infectious Diseases study yesterday.
More than two thirds of antibiotics prescribed for respiratory tract infections at primary care practices within an academic health system were inappropriate, with unnecessary prescribing strongly linked to respiratory infections that almost never require antibiotics, researchers reported today in Infection Control & Hospital Epidemiology.
Thirty-seven million Americans planned to travel 50 or more miles over the weekend, up 14 million from last year.
WHO advisors have approved emergency listing for China's two-dose vaccine.
IQVIA's 5-year forecast estimates the pandemic's effects on the global pharmaceutical market.
About 90% of cancer patients had adequate coronavirus antibodies after vaccination.
COVID-19 infection was 94% less likely in people previously infected than in those never infected, according to a research letter late last week in JAMA Internal Medicine. However, the researchers note, their study concluded before COVID-19 variants became dominant.
CARB-X announced today that it is awarding Swiss pharmaceutical company BioVersys up to $4.35 million to develop a new class of antibiotics to treat life-threatening infections caused by multidrug-resistant bacteria.
